Keyphrases
Arabidopsis Thaliana
100%
Freezing Tolerance
66%
Lipids
66%
Rosette
66%
Lipid Levels
61%
Leaf Lipids
33%
Cell Treatment
33%
B Cells
33%
Multiple Sclerosis
33%
Heat Stress
33%
Galactolipid
33%
Lipid Modification
33%
Relapsing-remitting multiple Sclerosis
33%
Anti-CD20
33%
Ion Leakage
30%
Sterol Glucosides
22%
Monogalactosyldiacylglycerol
22%
12-oxo-phytodienoic Acid Reductase
22%
Sterols
22%
Specific Lipids
22%
Anti-B Cell Therapy
22%
Glycosylation
22%
Reductase
20%
Freeze-thaw Treatment
19%
Lipoxygenase
15%
PNPLA3
15%
Sterol Esters
12%
Ublituximab
11%
Lytic Therapy
11%
Plant Freezing
11%
Plant Lipids
11%
Direct Infusion
11%
Freezing Temperature
11%
Mechanism of Action
11%
Membrane Lipids
11%
Sulfoquinovosyldiacylglycerol
11%
Clinical Efficacy
11%
Enzyme Activity
11%
Anti-CD20 Antibody
11%
Acyl
11%
Primary Progressive
11%
Elevated Temperature
11%
Lipid Species
11%
Acylate
11%
Plant Leaves
11%
Head Group
11%
Fatty Acyl Chains
11%
Extreme Heat Stress
11%
Treatment Level
11%
Acyl Chain
11%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Arabidopsis thaliana
100%
Rosette Formation
66%
Freezing Tolerance
66%
Wild Type
46%
Lipid Level
38%
Heat Stress
33%
Sterol
33%
Metabolite
33%
Reductase
27%
Oxidoreductase
27%
Galactolipid
25%
Glycosylation
16%
Acclimatization
11%
Sterol Ester
10%
Patatin-Like Phospholipase
8%
Lipoxygenase
8%
Triglyceride
8%
Phosphatidic Acid
8%
Phosphatidylglycerol
8%
Lipid Composition
8%
Acylation
8%
Mass Spectrometry
8%
Alpha Oxidation
8%
Enzyme
8%
Membrane Lipid
8%
Tandem Mass Spectrometry
5%
Electrospray Ionization
5%
Immunology and Microbiology
Arabidopsis thaliana
66%
Wild Type
44%
Freezing Tolerance
33%
Heat Stress
33%
Metabolite
33%
CD20
33%
B Cell
33%
Multiple Sclerosis
33%
Rosette Formation
33%
Lipid Level
27%
Glycosylation
22%
Rituximab
13%
Acylation
11%
Lipid Composition
11%
Plant Leaf
11%
Ublituximab
6%
Ocrelizumab
6%
Ofatumumab
6%
